Wednesday, October 21, 2020
3PM-4PM CET / 9 AM-10AM EST
eConsent is rapidly becoming the new consent standard for trials. Due to COVID and a general need to simplify the consent and tracking process, more and more trials are using this solution. In our webinar, we will look into selecting the right eConsent solution to your study type and how to simplify the eSignature process for the patient.
Site benefits of eConsent are essential, and most sites find eConsent is easier to use and makes it easy to fulfil the regulatory requirements. We will go through the site process of using eConsent for both initial- and re-consent, and how this is linked to randomization and EDC.
John is the founder of the company. He has worked for 7 years at a subsidiary of Novo Nordisk A/S, as VP for eClinical Process Consulting, specializing in clinical processes in R&D and execution of eClinical programs. Before Novo, he worked for 5 years as CIO in IBM Denmark, and prior to that in IT and Clinical Operations at Henri Beaufour Institute Inc. in the US.
Sarah is a Pharma Business and IT Consultant. She specializes in IT Quality, running IT implementation projects, optimizing business processes and developing quality documentation (SOPs) for computerized systems in Life Science.
Sarah has a strong background within pharmaceutical research, biopharmaceutical production and documentation and has a Master of Science in Engineering in Biotechnology. She has an analytical mindset and is driven by solving problems and making a difference. Before joining HERAX, Sarah has work in both research at the University of Copenhagen and in production in the pharmaceutical industry.